NCT06630377
GOS and the Management of Hyperuricemia
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Change of serum uric acid
Timeframe: from baseline to 8 weeks after intervention
Change of excretion of uric acid
Timeframe: from baseline to 8 weeks after intervention
Secondary (2)
Change of gut microbiota
Change of microbial metabolites in the circulation
Arms and interventions
Dietary intervention with GOSExperimental
Eligible subjects are instructed to take one pocket of galactooligosaccharide during the first week, followed by two pockets of galactooligosaccharide during the remaining 7 weeks.
Dietary intervention with PlaceboPlacebo comparator
Eligible subjects are instructed to take one pocket of maltodextrin during the first week, followed by two pockets of maltodextrin during the remaining 7 weeks.
Dietary supplements: GOS, Placebo
Sites
1 site in 1 country
- Sun Yat-Sen UniversityGuangzhou, Guangdong, China